12 results
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
brand. Mr. Vann has significant experience in global lifecycle management of oncology products as well as implementing marketing strategy
8-K/A
EX-99.1
AUTL
Autolus Therapeutics plc
15 Mar 24
Results of Operations and Financial Condition
4:21pm
think about the lifecycle management for obe-cel, it goes into two directions. There's obe-cel itself, and then obviously, AUTO1/22, which is the dual
6-K
EX-1
AUTL
Autolus Therapeutics plc
26 May 20
Current report (foreign)
4:31pm
cancer commercial team and general management of the Tarceva brand. Mr. Vann has significant experience of global lifecycle management of oncology
20-F
md3ipsfm129dom
23 Nov 18
Annual report (foreign)
12:00am
424B4
dzq8h2
22 Jun 18
Prospectus supplement with pricing info
4:02pm
F-1/A
ezhh3m9xnferlx
19 Jun 18
Registration statement (foreign) (amended)
8:05am
F-1/A
lpwsgta35k7ve7ulg
8 Jun 18
Registration statement (foreign) (amended)
6:25am
F-1/A
lbz eslwy
10 May 18
Registration statement (foreign) (amended)
5:19pm
F-1
lp7mgy6vqr1zp3p9
7 May 18
Registration statement (foreign)
4:45pm
- Prev
- 1
- Next